This page is part of the FHIR Specification (v5.0.0-ballot: FHIR R5 Ballot Preview). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
Patient Care Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw Turtle (+ also see Turtle/RDF Format Specification)
Example of conditiondefinition
@prefix fhir: <http://hl7.org/fhir/> . @prefix loinc: <http://loinc.org/rdf#> . @prefix owl: <http://www.w3.org/2002/07/owl#> . @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> . @prefix sct: <http://snomed.info/id/> . @prefix xsd: <http://www.w3.org/2001/XMLSchema#> . # - resource ------------------------------------------------------------------- [a fhir:ConditionDefinition; fhir:nodeRole fhir:treeRoot; fhir:Resource.id [ fhir:value "example"]; fhir:DomainResource.text [ fhir:Narrative.status [ fhir:value "generated" ]; fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: ConditionDefinition</b><a name=\"example\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource ConditionDefinition "example" </p></div><p><b>url</b>: <code>http://hl7.org/fhir/ConditionDefinition/example</code></p><p><b>identifier</b>: id: urn:oid:2.16.840.1.113883.4.642.25.1</p><p><b>name</b>: Hyperlipidemia</p><p><b>title</b>: Hyperlipidemia Status</p><p><b>status</b>: draft</p><p><b>date</b>: 2019-05-26T10:44:00+10:00</p><p><b>code</b>: Hyperlipidemia (disorder) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#55822004)</span></p><p><b>hasSeverity</b>: false</p><p><b>hasBodySite</b>: false</p><p><b>hasStage</b>: false</p><p><b>definition</b>: <a href=\"https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf\">https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf</a></p><blockquote><p><b>observation</b></p><p><b>code</b>: Lipid Panel <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#24331-1 "Lipid 1996 panel - Serum or Plasma")</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: Cholesterol <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#35200-5 "Cholesterol [Moles/volume] in Serum or Plasma")</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: Triglyceride <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#35217-9 "Triglyceride [Moles/volume] in Serum or Plasma")</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: Cholesterol in HDL <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#2085-9 "HDL Cholesterol")</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: LDL Chol. (Calc) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#13457-7 "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation")</span></p></blockquote><h3>Medications</h3><table class=\"grid\"><tr><td>-</td><td><b>Code</b></td></tr><tr><td>*</td><td>Gemfibrozil <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#203151)</span></td></tr></table><h3>Plans</h3><table class=\"grid\"><tr><td>-</td><td><b>Reference</b></td></tr><tr><td>*</td><td><a href=\"todo.html\">http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6</a></td></tr></table></div>" ]; fhir:ConditionDefinition.url [ fhir:value "http://hl7.org/fhir/ConditionDefinition/example"]; fhir:ConditionDefinition.identifier [ fhir:index 0; fhir:Identifier.system [ fhir:value "urn:ietf:rfc:3986" ]; fhir:Identifier.value [ fhir:value "urn:oid:2.16.840.1.113883.4.642.25.1" ] ]; fhir:ConditionDefinition.name [ fhir:value "Hyperlipidemia"]; fhir:ConditionDefinition.title [ fhir:value "Hyperlipidemia Status"]; fhir:ConditionDefinition.status [ fhir:value "draft"]; fhir:ConditionDefinition.date [ fhir:value "2019-05-26T10:44:00+10:00"^^xsd:dateTime]; fhir:ConditionDefinition.code [ fhir:CodeableConcept.coding [ fhir:index 0; a sct:55822004; fhir:Coding.system [ fhir:value "http://snomed.info/sct" ]; fhir:Coding.code [ fhir:value "55822004" ]; fhir:Coding.display [ fhir:value "Hyperlipidemia (disorder)" ] ] ]; fhir:ConditionDefinition.hasSeverity [ fhir:value "false"^^xsd:boolean]; fhir:ConditionDefinition.hasBodySite [ fhir:value "false"^^xsd:boolean]; fhir:ConditionDefinition.hasStage [ fhir:value "false"^^xsd:boolean]; fhir:ConditionDefinition.definition [ fhir:value "https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf"; fhir:index 0 ]; fhir:ConditionDefinition.observation [ fhir:index 0; fhir:ConditionDefinition.observation.code [ fhir:CodeableConcept.coding [ fhir:index 0; a loinc:24331-1; fhir:Coding.system [ fhir:value "http://loinc.org" ]; fhir:Coding.code [ fhir:value "24331-1" ]; fhir:Coding.display [ fhir:value "Lipid 1996 panel - Serum or Plasma" ] ]; fhir:CodeableConcept.text [ fhir:value "Lipid Panel" ] ] ], [ fhir:index 1; fhir:ConditionDefinition.observation.code [ fhir:CodeableConcept.coding [ fhir:index 0; a loinc:35200-5; fhir:Coding.system [ fhir:value "http://loinc.org" ]; fhir:Coding.code [ fhir:value "35200-5" ]; fhir:Coding.display [ fhir:value "Cholesterol [Moles/volume] in Serum or Plasma" ] ]; fhir:CodeableConcept.text [ fhir:value "Cholesterol" ] ] ], [ fhir:index 2; fhir:ConditionDefinition.observation.code [ fhir:CodeableConcept.coding [ fhir:index 0; a loinc:35217-9; fhir:Coding.system [ fhir:value "http://loinc.org" ]; fhir:Coding.code [ fhir:value "35217-9" ]; fhir:Coding.display [ fhir:value "Triglyceride [Moles/volume] in Serum or Plasma" ] ]; fhir:CodeableConcept.text [ fhir:value "Triglyceride" ] ] ], [ fhir:index 3; fhir:ConditionDefinition.observation.code [ fhir:CodeableConcept.coding [ fhir:index 0; a loinc:2085-9; fhir:Coding.system [ fhir:value "http://loinc.org" ]; fhir:Coding.code [ fhir:value "2085-9" ]; fhir:Coding.display [ fhir:value "HDL Cholesterol" ] ]; fhir:CodeableConcept.text [ fhir:value "Cholesterol in HDL" ] ] ], [ fhir:index 4; fhir:ConditionDefinition.observation.code [ fhir:CodeableConcept.coding [ fhir:index 0; a loinc:13457-7; fhir:Coding.system [ fhir:value "http://loinc.org" ]; fhir:Coding.code [ fhir:value "13457-7" ]; fhir:Coding.display [ fhir:value "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation" ] ]; fhir:CodeableConcept.text [ fhir:value "LDL Chol. (Calc)" ] ] ]; fhir:ConditionDefinition.medication [ fhir:index 0; fhir:ConditionDefinition.medication.code [ fhir:CodeableConcept.coding [ fhir:index 0; fhir:Coding.system [ fhir:value "http://www.nlm.nih.gov/research/umls/rxnorm" ]; fhir:Coding.code [ fhir:value "203151" ]; fhir:Coding.display [ fhir:value "Gemfibrozil" ] ] ] ]; fhir:ConditionDefinition.plan [ fhir:index 0; fhir:ConditionDefinition.plan.reference [ fhir:link <http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6>; fhir:Reference.reference [ fhir:value "http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6" ] ] ]] . # - ontology header ------------------------------------------------------------ [a owl:Ontology; owl:imports fhir:fhir.ttl] . # -------------------------------------------------------------------------------------
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.